healthcare life sciences

ヘルスケア・ライフサイエンス

Select your office

Changing gears to deliver CAR-T in your hospital

Enabling operational readiness for CAR-T therapy delivery in a hospital

Healthcare & life sciences

Future health

How the industry will move from “one size fits all” to “ultra-targeted” care

Healthcare & life sciences

Maximizing the rare chance of launch success with orphan

A strategic approach to achieving launch excellence and success for rare-disease medicines

Healthcare & life sciences

The intelligent pharmaceutical supply chain

Enable a superior patient-and-caregiver experience with a leading-edge digital supply chain

The combination of new drugs, new treatments and advanced data analytics solutions creates superior opportunities for patients, making treatment more effective, more affordable and less intrusive, with a positive impact on their quality of life.This evolution will bring fundamental changes in the...
Healthcare & life sciences

The BIG patent expiry question: Why sink when you can sail?

Riding the wave of medicine loss-of-exclusivity to gain improved returns

As a biopharmaceutical product approaches the end of its patent life, executives believe that the product’s demise is inevitable and will happen at great speed. They begin to worry about the rapid loss of revenue that will be brought about by the entry of generic alternatives into the market. They...
Healthcare & life sciences

Digitalization trends in the health care industry

ConhIT report: Health care shows great promise for digitalization initiatives

What are the next steps?Show courage regarding technology innovation and tackle digitalization proactively:Take advantage of impulses from technology, openness of both politics and regulation, and increasing customer acceptanceGather experiences with pilot projects in process automation, e.g.,...
Healthcare & life sciences, Technology & innovation management

Pharmacovigilance literature review in the age of

Injecting technology solutions into the literature-review Process

Over the years, pharmacovigilance (PV) processes have involved PV professionals manually going through high volumes of data to identify, assess and report adverse event (AE) information. This set-up will face increasing challenges, as more and more work needs to be done in fixed amounts of time....
Healthcare & life sciences

Finding the needle in the PV haystack

Injecting technology solutions into the literature review process in pharmacovigilance (PV)

Many life science companies are exploring, with limited success, the application of digital technologies to business operations. One area that has failed in recent years to deliver the promised benefits or required quality is the automation of scientific and medical literature review for reportable...
Healthcare & life sciences

Transforming medical technology businesses to create value

There is significant value to be captured with digital products and services in the healthcare industry. However, existing medical technology companies going digital will require major business and operational model changes. This article ...
Healthcare & life sciences, Digital company transformation

The advent of consumer owned genetic profiles

Personal genetic services due for explosive growth

Access to genetic information is becoming critical to the effectiveness of a new wave of medical treatments that are becoming available now. Personalized genetic services companies will act as a disruptive forces that are consumerizing genomic testing and driving rapid transformation...
Healthcare & life sciences